Actively Recruiting

Age: 12Years +
All Genders
NCT06156384

Study to Assess the Pain, Satisfaction, and Quality of Life of Patients With FITBONE® Lengthening Nail

Led by Orthofix s.r.l. · Updated on 2025-08-28

45

Participants Needed

6

Research Sites

262 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a prospective observational non-interventional multi-centre cohort study of patients, 12 years or older, initiating a lower limb lengthening procedure with FITBONE and who have a length discrepancy of 30mm or more between the limbs. The following parameters will be assessed for up to 24 months. * Pain using the Visual Analog Scale (VAS), Patient Global Assessment (PGA) and Clinical Observer Global Assessment (COGA) * Patient satisfaction using the Patient Global Impression of change (PGI-C) scale * QoL using the 36-Item Short Form Survey/Paediatric Quality of Life Inventory (SF-36/PedsQL)

CONDITIONS

Official Title

Study to Assess the Pain, Satisfaction, and Quality of Life of Patients With FITBONE® Lengthening Nail

Who Can Participate

Age: 12Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 12 years or older with congenital or acquired lower limb discrepancy greater than 30mm undergoing femoral or tibia bone lengthening with FITBONE
  • Patients with a regular indication for surgical intervention with FITBONE according to manufacturer instructions
  • Patient or legally acceptable representative can understand the informed consent form
  • Informed consent form is correctly obtained
Not Eligible

You will not qualify if you...

  • Patients with medical conditions contraindicated according to FITBONE instructions for use
  • Patients with conditions that may interfere with study execution or likely to be lost to follow-up as judged by the investigator
  • Patients with medical conditions posing safety concerns or interfering with study participation as judged by the investigator
  • Patients requiring or having concomitant devices that cannot be safely removed (except permitted devices)
  • Patients participating in or having participated in another clinical study within the last 3 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

CHU de Saint-Étienne Hôpital Nord

Saint-Etienne, Auvergne-Rhône-Alpes, France, 42270

Actively Recruiting

2

CHU de Strasbourg

Strasbourg, Grand Est, France, 67091

Actively Recruiting

3

CHU Lille - Hôpital Jeanne de Flandre

Lille, Hauts-de-France, France, 59120

Actively Recruiting

4

Centre hospitalier universitaire (CHU) de Toulouse

Toulouse, Occitanie, France, 31300

Actively Recruiting

5

Hôpital Sainte-Marguerite AP-HM

Marseille, Provence-Alpes-Côte d'Azur Region, France, 13274

Actively Recruiting

6

CHU de La Réunion site Sud Saint-Pierre

Saint-Pierre, La Réunion, Reunion, 97448

Actively Recruiting

Loading map...

Research Team

T

Tommaso Marano

CONTACT

D

Daniela Cangiano

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here